The financing was actually done at 1 dollar with the stock at 85 cents. Investors paid 88 cents for the stock plus 12 cents for the right to exercise warrants. Its a creative way to get to 1 dollar. The investors, who are some of the smartest Biotech investors around obviously have great faith that the APPA drug will be approved by the FDA or else their investment makes no sense.